Skip to main content

Olalla Pancorbo Rosal

Institutions of which they are part

Research technician
Stroke research
Vall Hebron Institut de Recerca

Olalla Pancorbo Rosal

Institutions of which they are part

Research technician
Stroke research
Vall Hebron Institut de Recerca

Projects

Influencia de factores clínicos, marcadores de neuroimagen y parámetros de laboratorio en el control de la presión arterial tras una hemorragia intracerebral aguda

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Manuel Requena Ruiz, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 40000
Reference: PI23/01061
Duration: 01/01/2024 - 31/12/2026

Papel de la proteína MFGE8 como potencial biomarcador y diana terapéutica en la angiopatía amiloide cerebral

IP: Maria Mar Hernandez Guillamon
Collaborators: Berta Paez Montserrat, Kerrie Adrián Campbell, Jessica Camacho Soriano, Anas Chaachou Charradi, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 208750
Reference: PI23/00082
Duration: 01/01/2024 - 31/12/2026

Empower-ICH: eficacia de la implementación de un sistema de telemonitorización de la presión arterial ambulatoria en pacientes con hemorragia intracerebral

IP: David Rodriguez Luna
Collaborators: Noelia Rodríguez Villatoro, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 38720
Reference: PI20/00834
Duration: 01/01/2021 - 30/06/2025

Implicaction of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy

IP: Maria Mar Hernandez Guillamon
Collaborators: Marcel Lamana Vallverdu, Jessica Camacho Soriano, Olga Maisterra Santos, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 169400
Reference: PI20/00465
Duration: 01/01/2021 - 30/06/2025

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Elisabet Miro Casas

Elisabet Miro Casas

Research technician
Cardiovascular Diseases
Read more
Edurne Ruiz Marti

Edurne Ruiz Marti

Infectious Diseases
Read more
Ariadna Campos Martorell

Ariadna Campos Martorell

Growth and Development
Read more
Marta Aguayo Álvarez

Marta Aguayo Álvarez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.